Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fearon E. R., Pardoll D. M., Itaya T., Golumbek P., Levitsky H. I., Simons J. W., Karasuyama H., Vogelstein B., Frost P. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell. 1990 Feb 9;60(3):397–403. doi: 10.1016/0092-8674(90)90591-2. [DOI] [PubMed] [Google Scholar]
- Nakamura Y., Tokuda Y., Iwasawa M., Tsukamoto H., Kidokoro M., Kobayashi N., Kato S., Mitomi T., Habu S., Nishimura T. Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy. Br J Cancer. 1992 Jul;66(1):20–26. doi: 10.1038/bjc.1992.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nishimura T., Nakamura Y., Takeuchi Y., Gao X. H., Tokuda Y., Okumura K., Habu S. Bispecific antibody-directed antitumor activity of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus interleukin 2. Jpn J Cancer Res. 1991 Nov;82(11):1207–1210. doi: 10.1111/j.1349-7006.1991.tb01782.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nishimura T., Nakamura Y., Takeuchi Y., Tokuda Y., Iwasawa M., Kawasaki A., Okumura K., Habu S. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy. J Immunol. 1992 Jan 1;148(1):285–291. [PubMed] [Google Scholar]
- Nishimura T., Nakamura Y., Tsukamoto H., Takeuchi Y., Tokuda Y., Iwasawa M., Yamamoto T., Masuko T., Hashimoto Y., Habu S. Human c-erbB-2 proto-oncogene product as a target for bispecific-antibody-directed adoptive tumor immunotherapy. Int J Cancer. 1992 Mar 12;50(5):800–804. doi: 10.1002/ijc.2910500523. [DOI] [PubMed] [Google Scholar]
- Osband M. E., Lavin P. T., Babayan R. K., Graham S., Lamm D. L., Parker B., Sawczuk I., Ross S., Krane R. J. Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic renal-cell carcinoma. Lancet. 1990 Apr 28;335(8696):994–998. doi: 10.1016/0140-6736(90)91064-h. [DOI] [PubMed] [Google Scholar]
- Panzer S., Geller R. L., Bach F. H. Purified human T cells stimulated with cross-linked anti-CD3 monoclonal antibody OKT3: rIL-1 is a co-stimulatory factor for CD4+CD29+CD45RA- T cells. Scand J Immunol. 1990 Oct;32(4):359–371. doi: 10.1111/j.1365-3083.1990.tb02930.x. [DOI] [PubMed] [Google Scholar]